News

2023

2022

2021

2020

Mar 14, 2023
Mindset Pharma To Defend Against Lawsuit Filed By Reunion Neurosciences
Read more
Read more
Mindset Pharma To Defend Against Lawsuit Filed By Reunion Neurosciences
Mar 14, 2023
Read more
Read more
Mar 06, 2023
Mindset Pharma and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin Into Growing Australian Market via Sales Partnership
Read more
Read more
Mindset Pharma and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin Into Growing Australian Market via Sales Partnership
Mar 06, 2023
Read more
Read more
Feb 02, 2023
Mindset Pharma Receives Another Allowance from USPTO for Patent Application Expanding Composition of Matter for Family 1 Psilocybin Analogs
Read more
Read more
Mindset Pharma Receives Another Allowance from USPTO for Patent Application Expanding Composition of Matter for Family 1 Psilocybin Analogs
Feb 02, 2023
Read more
Read more
Jan 20, 2023
Mindset Pharma Receives Allowance for U.S. Patent Application Covering Composition of Matter for Its Lead Psychedelic Therapeutic Candidate, MSP-1014, And Additional Family 1 Tryptamine Prodrug Candidates
Read more
Read more
Mindset Pharma Receives Allowance for U.S. Patent Application Covering Composition of Matter for Its Lead Psychedelic Therapeutic Candidate, MSP-1014, And Additional Family 1 Tryptamine Prodrug Candidates
Jan 20, 2023
Read more
Read more
Get to know us
Let Us Help You
Join the Conversation
Linkedin Youtube Instagram Twitter Facebook
Subscribe
Get Updates
Copyright © 2023 Mindset Pharma All rights reserved. | Disclaimer & Privacy Policy
Subscribe for latest news